编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
20178121 | GNE-272 | 1936428-93-1 | 98% | |
GNE-272对CBP / EP300的溴域具有很强的选择性(CBP IC50 = 0.02 μM, EP300 IC5 | ||||
17030702 | 胍氯酚 | 5001-32-1 | 98% | |
胍氯酚是一种抗高血压的药物。 | ||||
17030701 | GRA Ex-25 | 307983-31-9 | 98% | |
GRA Ex-25是胰高血糖素受体的抑制剂。 | ||||
16123016 | GTS-21 | 156223-05-1 | 98% | |
GTS-21, also known as DMBX-A, is a derivative of the natural product anabaseine that | ||||
16123015 | GSK6853 (GSK-6853) | 1910124-24-1 | 98% | |
GSK6853 is a potent (300 pM), soluble, cell active (20 nM), and highly selective inhi | ||||
16123014 | GSK583 | 1346547-00-9 | 98% | |
GSK583 is a Highly Potent and Selective Inhibitor of RIP2 Kinase (RIP2K bing IC50=5 n | ||||
16123013 | GSK369796 Dihydrochloride | 1010411-21-8 | 98% | |
GSK369796, also known as N-tert-butylisoquine, is an anti-malaria drug candidate. GSK | ||||
16123012 | GSK2801 | 1619994-68-1 | 98% | |
GSK2801 is a A Selective Chemical Probe for BAZ2B/A bromodomains. BAZ2A/B belong to a | ||||
16123011 | GSK-2256098 | 1224887-10-8 | 98% | |
GSK2256098, also known as GTPL7939, is a focal adhesion kinase-1 (FAK) inhibitor with | ||||
16123010 | GSK137647A | 349085-82-1 | 98% | |
GSK137647A is an agonist of the free fatty acid receptor 4 (FFA4/GPR120) with pEC50s | ||||
16123009 | GSK0660 | 1014691-61-2 | 98% | |
GSK0660 is a selective PPAR antagonist. GSK0660 differentially regulated 273 transcri | ||||
16123008 | Go6983 | 133053-19-7 | 98% | |
GO6983 is a potent protein kinase C (PKC) inhibitor. GO6893 displays cardioprotective | ||||
16123007 | GNE-617 | 1362154-70-8 | 98% | |
GNE-617 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with IC5 | ||||
16123006 | GlyH-101 | 328541-79-3 | 98% | |
GlyH-101 is a CFTR inhibitor (cystic fibrosis transmembrane conductance regulator). G | ||||
16123005 | GLPG-1690(ziritaxestat) | 1628260-79-6 | 98% | |
GLPG1690 is a selective autotaxin inhibitor discovered by Galapagos, with potential a | ||||
16123004 | GDC-0853 | 1434048-34-6 | 98% | |
GDC-0853 is orally available inhibitor of Bruton's tyrosine kinase (BTK) with potenti | ||||
16122815 | GABOB (beta-hydroxy-GABA) | 7013-05-0 | 98% | |
GABOB, also known as -Amino--hydroxybutyric acid, -hydroxy--aminobutyric acid, -hydro | ||||
16122814 | Gabexate mesylate | 56974-61-9 | 98% | |
Gabexate is a serine protease inhibitor which is used therapeutically (as gabexate me | ||||
16122787 | Glasdegib (PF-04449913) | 1095173-27-5 | 98% | |
Glasdegib (PF-04449913) is a potent, and orally bioavailable Smoothened (Smo) inhibit | ||||
16122723 | Go6976 | 136194-77-9 | 98% | |
Go6976 is a potent PKC inhibitor with IC50 of 7.9 nM, 2.3 nM, and 6.2 nM for PKC (Rat | ||||
16122702 | GSK2292767 | 1254036-66-2 | 98% | |
GSK2292767 is a potent and selective PI3K inhibitor.GSK2292767 is highly selective fo | ||||
6111521 | GSK2981278 | 1474110-21-8 | 98% | |
ROR modulator 1 is a retinoid-related orphan receptor gamma (RORy) modulator, extract | ||||
6111015 | GSK163090 | 844903-58-8 | 98% | |
GSK163090 is a potent, selective, and orally active 5-HT1A/B/D receptor antagonist wi | ||||
6111009 | GSK-591 | 1616391-87-7 | 98% | |
EPZ015866 (GSK591) is a potent selective inhibitor of the arginine methyltransferase | ||||
611826 | GSK2269557 free base | 1254036-71-9 | 98% | |
GSK-2269557 (free base) is a potent and selective PI3Kδ inhibitor over the closely r | ||||
611807 | GSK2141795 (hydrochloride) | 1047635-80-2 | 98% | |
GSK2141795 Hcl is a potent and selective pan-Akt inhibitor with IC50 values of 180 nM | ||||
161009019 | GSK-690693 | 937174-76-0 | 98% by HPLC | |
Pan-AKT kinase inhibitor GSK-690693 binds to and inhibits Akt kinases 1, 2, and 3, wh | ||||
1681201 | GX-674 | 1432913-36-4 | 98% by HNMR/HPLC | |
GX-674 is an aryl sulfonamide class of antagonists that inhibits Nav1.7.Nav (voltage- | ||||
16071405 | GDC-0084 | 1382979-44-3 | 98% by HPLC | |
GDC-0084, also known as RG7666, is a phosphatidylinositol 3-kinase (PI3K) inhibitor w | ||||
16071110 | GRT-6005 | 863513-91-1 | 98% by HPLC | |
Cebranopadol is a potent nociceptin/orphanin FQ peptide (NOP) and opioid receptor ago |